Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients
about
Cachexia and pancreatic cancer: are there treatment options?Cancer cachexia: impact, mechanisms and emerging treatmentsClinical anticachexia treatments.New drugs for the anorexia-cachexia syndrome.Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Cancer-related cachexia and oxidative stress: beyond current therapeutic options.Management of paraneoplastic syndromes in lung cancer.The relationship between weight loss and interleukin 6 in non-small-cell lung cancerAdipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.Changes in nutritional status associated with unresectable pancreatic cancer.A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patientsImmunomodulation in surgical practice.Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review.Current pharmacotherapy options for cancer anorexia and cachexia.Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response.Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic.Influence of an elevated nutrition risk score (NRS) on survival in patients following gastrectomy for gastric cancer.Acceptability and tolerance of a low tyrosine and phenylalanine diet in patients with advanced cancer -- a pilot study.Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients.
P2860
Q27026558-EC5D850E-7BBF-485A-9BE0-8E31217F7B9FQ28384479-7B50AEAE-0126-4DE9-AB74-D624DDE9980EQ33994400-8C646E53-3B8E-476E-A2F6-62798EFF96EDQ34590839-510904CE-4206-45C8-87B7-61A34BB9D8AEQ34636946-82B6C9FE-C67E-4605-B115-4E8511C7AC42Q34660312-F6DAC17D-1418-47FC-93A9-2752EA8A34E7Q35122201-72B94B2C-7444-4433-9B67-A836E1DAEE26Q35160222-C3A00518-1F49-4DD5-8146-484E51387184Q35617154-B749EFA0-AAD1-4ADF-B3BF-401FF2CC1FDDQ36135375-CB90FE63-E941-423F-AAD6-685DC931E67AQ36213681-64BFB7DA-B3BF-4549-8B2C-65DC54299BE8Q36419986-6C5577A0-AFC6-4187-AE79-6087DFF7FAA1Q36431112-9F9DCD39-D990-469F-9DFE-5821A80BE4DEQ37107283-A86B51A8-2457-4CD0-8C2F-4BFFADEAF06EQ38047351-6CF78744-452C-4961-BF64-6E61493F985DQ38052613-90369392-6EAD-4330-9397-CE3762BB7BAAQ40212563-72826088-E56E-43BA-87FD-B0E657F361C5Q40771523-524C8041-DA50-4452-8C8E-C5DD8238EB19Q41673233-134B22EE-E211-406F-8828-22523854893FQ44004887-3962866A-C615-4513-8DA6-8893E46D5E05Q46990341-20CB4F4D-758B-488E-A75A-1D71331B90ECQ47272566-F8A9BAD8-DA35-4D50-9B67-9B52BDF28AB4
P2860
Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@ast
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@en
type
label
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@ast
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@en
prefLabel
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@ast
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@en
P2093
P2860
P356
P1476
Ibuprofen reduces energy expen ...... in pancreatic cancer patients
@en
P2093
C E Plester
D C Carter
J P Maingay
J S Falconer
K C Fearon
P2860
P2888
P304
P356
10.1038/BJC.1995.300
P407
P577
1995-07-01T00:00:00Z